Search By Initial

Cas Index 1

• 1279680-68-0 | CL2A-SN38 DCA (Catalog# : 2071556)CL2A-SN38 is a SN38 derivative with a peptide-linker which can easily react with anti
• 1846570-31-7 | CM-272 (Catalog# : 2071538)CM-272 is a first-in-class reversible dual small molecule inhibitor against G9a and D
• 189746-21-2 | 5-chloro-2,6-dimethoxy-4-methyl-8-nitroquinoline (Catalog# : 2062026)
• 1246964-32-8 | CLEFMA (Catalog# : 615201)CLEFMA has anti-proliferative activity in H441 cells. CLEFMA may induce autophagic ce
• 145915-58-8 | CGP52411 (Catalog# : 2061306)CGP52411, also known as DAPH, is a selective inhibitor of the epidermal growth factor
• 199735-88-1 | CADD522 (Catalog# : 2051505)CADD522 is a potent inhibitor of runt-related transcription factor-2 (RUNX2)-DNA bind
• 1010100-07-8 | CC-885 (Catalog# : 2041501)CC-885 is a potent Cereblon Modulator with potent antitumor activity mediated through
• 1860875-51-9 | CC-90009 (Catalog# : 203071)CC-90009 is a modulator of cereblon (CRBN), which is part of the cullin 4-RING E3 ubi
• 189746-19-8 | 5-Chloro-2,6-Dimethoxy-4-Methylquinoline (Catalog# : 4281903)5-Chloro-2,6-Dimethoxy-4-Methylquinoline, CAS 189746-19-8, is a key drug intermediate
• 1181083-81-7 | CLP-290 (Catalog# : 193286)CLP-290 is a novel KCC2 modulator and prodrug of CLP-257, highly selective for KCC2 o
• 1802632-22-9 | CT-1812 (Catalog# : 193283)CT-1812 is a first-in-class, orally available sigma-2/PGRMC1 antagonist (alpha beta o
• 1384860-29-0 | Conteltinib (Catalog# : 19342)Conteltinib is a tyrosine kinase inhibitor and an antineoplastic.
• 1358099-18-9 | C25-140 (Catalog# : 192274)C25-140 is the first in class protein-protein interaction inhibitor of a RING-E3 liga
• 1095382-05-0 | CCT-137690 (Catalog# : 192192)CCT137690, an aurora kinase inhibitor CCT137690, is a highly selective, orally bioava
• 1418274-28-8 | Cilofexor ( GS-9674 ) (Catalog# : 19132)Cilofexor (also known as GS-9674) is a nonsteroidal farnesoid X receptor (FXR) agonis
• 1402709-93-6 | CCT241736 (Catalog# : 1812283)CCT241736 is a potent and orally active and dual FLT3-Aurora inhibitor.
• 1801343-74-7 | CA-4948 (Catalog# : 1811292)CA-4948 is a bioactive chemical.
• 192322-50-2 | CGP-71683A HCl (Catalog# : 18792)CGP 71683A is a potent and highly selective non-peptide antagonist of the NPY Y(5) re
• 1437321-24-8 | CEP-40783 (Catalog# : 186281)CEP-40783, also known as RXDX-106, is a potent, selective and orally available inhibi
• 125316-60-1 | CD437 (Catalog# : 185316)CD437 is a synthetic retinoid that is an RARγ-selective agonist.
• 1345810-21-0 | CB-1158 (Catalog# : 185315)CB-1158, also known as INCB01158, is a potent arginase inhibitor.
• 153259-65-5 | Cilomilast (Catalog# : 185291)Cilomilast (Ariflo, SB-207,499) is a drug which was developed for the treatment of re
• 1276105-89-5 | CNX-1351 (Catalog# : 185174)CNX-1351 is a selective covalent Inhibitor of PI3Kα.
• 164658-13-3 | CGP60474 (Catalog# : 185171)CGP60474 is a potent dual cdk1/cdk2 inhibitor (IC50 values are 20 and 50 nM, respecti
• 1190932-38-7 | COH29 (Catalog# : 184127)COH29 is an orally available, aromatically substituted thiazole and inhibitor of the
• 1039455-84-9 | COTI-2 (Catalog# : 184320)COTI-2 is an P53 gene modulator and AKT2 inhibitor. OTI-2 is active against multiple
• 1202402-40-1 | CPI-444 (Catalog# : 18439)CPI-444, also known as V81444, is an orally administered antagonist of the adenosine
• 1443437-74-8 | CCG-203971 (Catalog# : 18437)CCG-203971 is an inhibitor of SRE activation in the prostate cancer cell line PC-3 (I
• 175140-00-8 | CP-376395游离 (Catalog# : 184213)CP-376395是一种CRF1的选择性拮抗剂。
• 1402152-13-9 | Copanlisib HCI (Catalog# : 18351)Copanlisib also known as BAY 80-6946, is a potent phosphoinositide 3-kinase (PI3K) in